Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus (2012)
- Authors:
- USP affiliated authors: MACEDO, CAROLINA SALES VIEIRA - FMRP ; DUARTE, GERALDO - FMRP ; QUINTANA, SILVANA MARIA - FMRP ; FERRIANI, RUI ALBERTO - FMRP
- Unidade: FMRP
- Subjects: MULHERES; HIV; DISPOSITIVOS ANTICONCEPCIONAIS (EFEITOS)
- Language: Inglês
- Imprenta:
- Source:
- Título: The European Journal of Contraception and Reproductive Health Care
- ISSN: 1362-5187
- Volume/Número/Paginação/Ano: v. 17, suppl. 1, p. S44, res. FC-31, 2012
- Conference titles: Congress of the European Society of Contraception and Reproductive Health
-
ABNT
MILENA, B. et al. Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus. The European Journal of Contraception and Reproductive Health Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 28 dez. 2025. , 2012 -
APA
Milena, B., Scaranari, C., Ferriani, R. A., Bahamondes, L., Bahamondes, V., Quintana, S. M., et al. (2012). Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus. The European Journal of Contraception and Reproductive Health Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Milena B, Scaranari C, Ferriani RA, Bahamondes L, Bahamondes V, Quintana SM, Duarte G, Amaral E, Vieira CS. Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus. The European Journal of Contraception and Reproductive Health Care. 2012 ; 17 S44.[citado 2025 dez. 28 ] -
Vancouver
Milena B, Scaranari C, Ferriani RA, Bahamondes L, Bahamondes V, Quintana SM, Duarte G, Amaral E, Vieira CS. Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus. The European Journal of Contraception and Reproductive Health Care. 2012 ; 17 S44.[citado 2025 dez. 28 ] - Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women
- Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy
- Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women
- Timing of etonogestrel-releasing implants and growth of breastfed infants: a randomized controlled trial
- Contracepção na adolescência
- Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome
- Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial
- Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial
- Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact
- Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel-releasing intrauterine system insertion in women without previous vaginal delivery
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
